Pharmafile Logo

Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development

- PMLiVE

Lucid Group is setting itself up for another stellar year with a new appointment to their senior leadership team. Rob Apollo has joined Lucid on a permanent basis as Director of Corporate Development.

Rob brings a wealth of experience in acquiring and integrating businesses, and also in supporting growing businesses and building infrastructure. Rob is totally aligned with the aspirations and culture of Lucid Group, having been on the board for the last 18 months, representing LDC, who made a minority investment in Lucid back in June 2017.

Rob’s appointment is part of Lucid’s wider growth strategy to acquire new capabilities, partnerships and companies to allow them to continually deliver industry-leading solutions for their clients and patients.

Rob commented, “I have seen the business continue to deliver best-in-class services to clients while maintaining market-leading organic growth. However, what really inspires me is Lucid’s purpose to help improve patients’ lives, which is at the heart of everything we do. I’m incredibly excited about what we’re going to achieve going forward. Let’s bring the magic.”

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My Journey Into MedComms #LucidLife

In NetworkPharma’s latest career guide for wannabe account managers, Tessa Rowland, Senior Account Executive, discusses her journey into the varied and fast-paced world of medical communications.

Lucid Group bolster its talent with a further twelve new starters for 2021

As if welcoming eight new graduates was not enough to bring some excitement to the start of the new year, Lucid Group has also welcomed a further twelve new employees...

The Lucid Group Futures Academy welcomes its 2021 cohort

This week Lucid welcomed its newest cohort of graduates onto the 2021 Futures Academy programme. The programme provides graduates with a 12-month structured medical writing training programme. It’s a chance...

Our People and their Growth are at the heart of #LucidLife

2020 has been a year like no other, in more ways than one. We wanted to shine a light on the good and great of 2020 and reflect on far...

Advance Outcomes named of the most innovative strategies of 2020 by PM360

PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Lucid Group’s pioneering behaviour-change methodology, Advance OutcomesTM, as one of...

Lucid Group Evolve and Simplify its Brand Architecture

The current pandemic has forced many industries to find new ways of working. Within medical communications (medcomms), this has involved pivoting quickly towards a digital-first approach in order to optimise...

Laurence Bannister joins Lucid Group as its new Chief Commercial Officer

Laurence brings a track record of success from 22 years’ experience in pharmaceuticals/healthcare – across affiliate, regional and global commercial roles – with the last 9 years being at STEM...

A Lucid Group Thirsty Thursday: change management and self-efficacy

Last week, Lucid Group were lucky enough to have Richard Nugent, Founder and Managing Director of TwentyOne Leadership, present a session on change management and self-efficacy. Richard often works with...

Lucid Group expand its UK office footprint in Macclesfield

Lucid Group is increasing its share of office space on the popular Tytherington Business Village, after a sustained period of growth, which has seen it outperform a buoyant marketplace and taken...

Lucid Group are keeping wellness front of mind

It's important to make sure that people are supported and encouraged to practice self-care throughout the year. This is why Lucid Group has been reminding its teams of the LucidBeing...